Tumour priming by ultrasound mechanogenetics for CAR T therapy
- PMID: 41174038
- DOI: 10.1038/s41563-025-02391-8
Tumour priming by ultrasound mechanogenetics for CAR T therapy
Abstract
Cell-based cancer immunotherapy holds potential as a therapeutic approach, yet its application for solid tumour treatment remains challenging. Here we report a focused-ultrasound-based approach that mechanically induces the localized expression of CD19 antigen within a subpopulation of cells within solid tumours, which function as local 'training centres' to activate chimeric antigen receptor T cells. Activated chimeric antigen receptor T cells attack the whole cancer cell population near the tumour site, thus achieving cancer suppression. The system achieves targeted gene expression by integrating focused-ultrasound-triggered mechanical stimulation and the subsequent calcium response of cancer cells with a doxycycline-gated AND-logic genetic circuit, both of which need to be active for effective induction of CD19 expression. We validate the functionality of the approach in vitro, in organoids and in vivo, achieving direct control of user-designed gene expressions through FUS-mediated mechanical stimulation without the need of any cofactor, demonstrating the approach's potential as a versatile platform for precisely controllable immunotherapy. Overall, our combinatorial approach offers a focused-ultrasound-controlled remote and non-invasive priming of solid tumours for effective and safe chimeric antigen receptor T cell immunotherapy via the induced production of clinically validated antigens.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: Yingxiao Wang is scientific cofounder and consultant of Cell E&G Inc. and Acoustic Cell Therapy Inc. These financial interests do not affect the design, conduct or reporting of this research. The other authors declare no competing interests.
References
-
- Shung, K. K. Diagnostic Ultrasound: Imaging and Blood Flow Measurements (Taylor & Francis, 2006).
Grants and funding
- EB029122/U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)
- K01EB035649/U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- GM140929/U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS)
- HL121365/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- HL121365/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- HL121365/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- HD107206/U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- T32 CA009523/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
